Salix mounts search for 64 new reps

They're hiring! Salix Pharmaceuticals, a Raleigh, NC-based drugmaker, is gearing up for a concerted assault on the market for ulcerative colitis and bowel cleansing meds, with plans to add some 64 sales reps. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.